3BT-18216-36623
1 vaccination
3 coded responses
4 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 321 / FL
- Registered
- 2021-01-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-02
Dose 1 — Moderna
-
2021-01-18
Registered in v-safe
-
2021-01-18
Survey response — day 14, dose 1MedDRA: Injected limb mobility decreased, Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Local reaction, Paraesthesia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Localized allergic reaction to vaccine. Including tingling in entire arm, 11x10 red, swollen, hot, sensitive to touch and movement in area where vaccine was injected into muscle.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-23
Survey response — day 21, dose 1MedDRA: Arthralgia, Inflammation, Medical counselling, Myalgia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Th reaction continues to flair up, I have joint and muscle pain. Inflammation continues to effect me. · Healthcare visit (other): PCPMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-23
Report sent to call center — day 21, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-01
Survey response — day 28, dose 1MedDRA: Heart rate increased, Immunisation reaction, Loss of personal independence in daily activities, Office visit, Paraesthesia, Specialist consultation — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Cannot get the 2nd dose since my 1st dose reaction is still ongoing and has not resolved with medical treatment. Still cannot perform daily activities normally. High heart rate, between 100 and 130 at rest. Entire arm still tingling. · Healthcare visit (other): PCP follow upMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Report sent to call center — day 28, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-22
Call successfulParticipant prefers to complete VAERS report online
- 2022-01-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-02 | Moderna |
Call center
3 call center cases
3 successful
Free text
Release 2 — day 14, dose 1
Symptoms: Localized allergic reaction to vaccine. Including tingling in entire arm, 11x10 red, swollen, hot, sensitive to touch and movement in area where vaccine was injected into muscle.
Release 2 — day 21, dose 1
Symptoms: Th reaction continues to flair up, I have joint and muscle pain. Inflammation continues to effect me.
Healthcare visit (other): PCP
Release 3 — day 28, dose 1
Symptoms: Cannot get the 2nd dose since my 1st dose reaction is still ongoing and has not resolved with medical treatment. Still cannot perform daily activities normally. High heart rate, between 100 and 130 at rest. Entire arm still tingling.
Healthcare visit (other): PCP follow up
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ✓ | ✓ | ✓ |
| HCVO | Office visit | ✓ | · | ✓ |
| HCVO | Specialist consultation | ○ | ✓ | ○ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Heart rate increased | ✓ | ✓ | ✓ |
| SD | Immunisation reaction | ✓ | · | ✓ |
| SD | Inflammation | ✓ | ✓ | ✓ |
| SD | Injected limb mobility decreased | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Local reaction | ✓ | ✓ | ✓ |
| SD | Loss of personal independence in daily activities | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release